Skip to content
Est. 1998 proudly celebrating 27 years of standing behind American companies
American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

Cencora, Inc. (COR)

$330.00 -0.30% NYSE: COR · 15-min delayed
  • CONSHOHOCKEN, Pennsylvania
  • Public · NYSE: COR
  • 51,000 employees
  • Founded 2001
$60.3BMarket cap
$321.3BRevenue · FY2025
$1.6BNet income
51,000Employees
CORNYSE
1995IPO

About Cencora, Inc.

Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health hold over 90% share of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.

This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.

Reported figures

Financial summary

Revenue FY2025
$321.3B
Net income
$1.6B
Total assets
$76.6B
Market cap
$60.3B

Source: SEC EDGAR · updated Jun 7, 2026

NYSE: COR
$330.00 -0.30%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$252.74 $374.75

52-week range

Market cap
$60.3B
Dividend yield
0.73%
Shares outstanding
182.7M
Open
—
Day range
–
Prev close
—
Volume
—
IPO date
Apr 4, 1995

Cencora, Inc. (COR) Stock Price

  • Profitable — net income of $1.6B in FY2025.
  • Trading 12% below its 52-week high.
  • Pays a dividend yielding about 0.73% annually.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review Cencora, Inc..

Write a review
Newsroom

News about Cencora, Inc.

News & sentiment via Polygon.io

FAQ

Cencora, Inc.: frequently asked questions

Is Cencora, Inc. an American company?

Yes — Cencora, Inc. is an American company. Cencora, Inc. is incorporated in Delaware, United States and headquartered in Conshohocken, Pennsylvania. Its legal-entity record reports no foreign parent — the company is independently American-owned.

Where is Cencora, Inc. incorporated?

Cencora, Inc. is legally incorporated in Delaware, United States, according to its GLEIF legal-entity record.

Who owns Cencora, Inc.?

Cencora, Inc. reports no parent company in its legal-entity record — it is independently owned rather than a subsidiary.

Is Cencora, Inc. traded on a US stock exchange?

Yes — Cencora, Inc. trades under the ticker COR on the NYSE.

Where is Cencora, Inc. headquartered?

Cencora, Inc. is headquartered in Conshohocken, Pennsylvania, United States.

Is Cencora, Inc. publicly traded?

Yes — Cencora, Inc. is a publicly traded company. Its stock trades under the ticker symbol COR on the NYSE.

What does Cencora, Inc. do?

Cencora, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.

When was Cencora, Inc. founded?

Cencora, Inc. was founded in 2001.

Explore

Similar companies

Browse all →